Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | Sci Rep | 2022 | 35915203 | PubTator, text mining | PubMed |
| CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma. | Proc Natl Acad Sci U S A | 2022 | 35914158 | PubTator, text mining | PubMed |
| Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence. | Stem Cells Int | 2022 | 35910534 | PubTator, text mining | PubMed |
| Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest. | Front Pharmacol | 2022 | 35910374 | PubTator, text mining | PubMed |
| Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma. | Chin Med | 2022 | 35907976 | PubTator, text mining | PubMed |
| Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation. | BMC Cancer | 2022 | 35907846 | PubTator, text mining | PubMed |
| Role of ferroptosis-related genes in coronary atherosclerosis and identification of key genes: integration of bioinformatics analysis and experimental validation. | BMC Cardiovasc Disord | 2022 | 35906548 | PubTator, text mining | PubMed |
| Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. | Nat Commun | 2022 | 35896530 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing of Cerebrospinal Fluid as an Advanced Form of Liquid Biopsy for Neurological Disorders. | Brain Sci | 2022 | 35884620 | PubTator, text mining | PubMed |
| Screening of Prognostic Markers for Hepatocellular Carcinoma Patients Based on Multichip Combined Analysis. | Comput Math Methods Med | 2022 | 35872941 | PubTator, text mining | PubMed |
| Architects of Pituitary Tumour Growth. | Front Endocrinol (Lausanne) | 2022 | 35837315 | PubTator, text mining | PubMed |
| Screening diagnostic markers for acute myeloid leukemia based on bioinformatics analysis. | Transl Cancer Res | 2022 | 35836534 | PubTator, text mining | PubMed |
| Aberrant Gene Expression Profiling in Men With Sertoli Cell-Only Syndrome. | Front Immunol | 2022 | 35833143 | PubTator, text mining | PubMed |
| The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and Therapy. | Front Genet | 2022 | 35832196 | PubTator, text mining | PubMed |
| Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis. | Front Oncol | 2022 | 35814478 | PubTator, text mining | PubMed |
| Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review. | Nutrients | 2022 | 35807785 | PubTator, text mining | PubMed |
| Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases. | Int J Mol Sci | 2022 | 35805898 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Points towards a Multi-Gene Synergistic Action in the Pathogenesis of Congenital Combined Pituitary Hormone Deficiency. | Cells | 2022 | 35805171 | PubTator, text mining | PubMed |
| Genetic association and single-cell transcriptome analyses reveal distinct features connecting autoimmunity with cancers. | iScience | 2022 | 35800769 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? | Cell Death Dis | 2022 | 35787632 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=26